Serratia marcescens peritoneal dialysis peritonitis: a clinical case and therapeutic approach

Authors

  • Hmaidouch Nabil Ibn Sina University Hospital Center, Department of Nephrology Dialysis Kidney Transplantation, Rabat, Morocco; Mohammed V University of Rabat, Faculty of Medicine and Pharmacy of Rabat, Morocco
  • Yacoubi Qods Ibn Sina University Hospital Center, Department of Nephrology Dialysis Kidney Transplantation, Rabat, Morocco; Mohammed V University of Rabat, Faculty of Medicine and Pharmacy of Rabat, Morocco
  • Dkhissi Rihab Ibn Sina University Hospital Center, Department of Nephrology Dialysis Kidney Transplantation, Rabat, Morocco; Mohammed V University of Rabat, Faculty of Medicine and Pharmacy of Rabat, Morocco
  • Ouzeddoun Naima Ibn Sina University Hospital Center, Department of Nephrology Dialysis Kidney Transplantation, Rabat, Morocco; Mohammed V University of Rabat, Faculty of Medicine and Pharmacy of Rabat, Morocco
  • Benamar Loubna Ibn Sina University Hospital Center, Department of Nephrology Dialysis Kidney Transplantation, Rabat, Morocco; Mohammed V University of Rabat, Faculty of Medicine and Pharmacy of Rabat, Morocco

DOI:

https://doi.org/10.22141/2307-1257.13.4.2024.483

Keywords:

catheter removal, peritonitis, peritoneal dialysis, Serratia marcescens

Abstract

Peritoneal dialysis (PD) is increasingly used as a kidney replacement therapy in end-stage kidney disease, especially for its benefits in patient management and quality of life. However, PD peritonitis, particularly when caused by Serratia marcescens, can be a challenging complication that may require catheter removal. We present the case of a 17-year-old patient who had three PD peritonitis episodes in less than six months, caused by Serratia marcescens that led to catheter removal. This bacteria is known for its resistance to antibiotics and potential for systemic dissemination, making prompt recognition and management crucial. Catheter removal may be necessary early on to prevent further complications and improve patient outcomes.

Downloads

Download data is not yet available.

References

Vasudevan A, Phadke K, Yap HK. Peritoneal dialysis for the management of pediatric patients with acute kidney injury. Pediatr Nephrol. 2017 Jul;32(7):1145-1156. doi: 10.1007/s00467-016-3482-6.

Khanna A, Khanna M, Aggarwal A. Serratia marcescens - a rare opportunistic nosocomial pathogen and measures to limit its spread in hospitalized patients. J Clin Diagn Res. 2013 Feb;7(2):243-246. doi: 10.7860/JCDR/2013/5010.2737.

Sasi S, Faraj H, Barazi R, et al. Endogenous endophthalmitis due to Serratia marcescens secondary to late-onset empyema Post-Cardiac surgery in an End-Stage renal disease patient on peritoneal dialysis. Clin Case Rep. 2023 Feb 24;11(2):e6997. doi: 10.1002/ccr3.6997.

Kilic I, Gungor K, Kurultak I, Ustundag S. Relapsing Serratia peritonitis resulting in peritoneal catheter loss. Saudi J Kidney Dis Transpl. 2018 Nov-Dec;29(6):1494-1497. doi: 10.4103/1319-2442.248298.

Zhao WH, Hu ZQ, Chen G, Matsushita K, Fukuchi K, Shimamura T. Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid. Microbiol Res. 2007;162(1):46-52. doi: 10.1016/j.micres.2006.06.005.

McCracken AW, Lipscomb FE. Serratia marcescens infection complicating peritoneal dialysis. Br Med J. 1965 Jun 12;1(5449):1536-1537. doi: 10.1136/bmj.1.5449.1536.

Hortling L, Sipilä R. Multiresistant Serratia marcescens peritonitis in a patient on continuous ambulatory peritoneal dialysis (CAPD) successfully treated with Azthreonam (S26,776) a new monobactam antibiotic. Clin Nephrol. 1984 Jun;21(6):355.

Bizette GA, Lindberg JS, Figueroa JE. Serratia marcescens peritonitis in a patient receiving chronic ambulatory peritoneal dialysis complicated by osteomyelitis. J La State Med Soc. 1995 Feb;147(2):64-67.

Tavares-Carreon F, De Anda-Mora K, Rojas-Barrera IC, Andrade A. Serratia marcescens antibiotic resistance mechanisms of an opportunistic pathogen: a literature review. PeerJ. 2023 Jan 5;11:e14399. doi: 10.7717/peerj.14399.

Vong O; French Society of Microbiology. The new CA-SFM recommendations have arrived. Available from: https://www.sfm-microbiologie.org/2023/06/02/le-nouveau-communique-du-ca-sfm-juin2023/.

Xie R, Ling Y, Huang Y, Qin L, Bao K, Qin X. A rare case of successful treatment of peritoneal dialysis patient with Serratia marcescens peritonitis without catheter removal: case report and literature review. Front Cell Infect Microbiol. 2024 May 30;14:1373036. doi: 10.3389/fcimb.2024.1373036.

Yang N, Li L. Successful treatment of Serratia Marcescens peritonitis in a patient receiving peritoneal dialysis. Clin Case Rep. 2020 Dec 11;9(2):796-799. doi: 10.1002/ccr3.3649.

Carranza AT. Dialysis-Associated Peritonitis due to Serratia marcescens: A Case Report. J Am Soc Nephrol. 2023 Nov;34(11S):1089. doi: 10.1681/ASN.20233411S11089b.

Connacher AA, Old DC, Phillips G, Stewart WK, Grimont F, Grimont PA. Recurrent peritonitis caused by Serratia marcescens in a diabetic patient receiving continuous ambulatory peritoneal dialysis. J Hosp Infect. 1988 Feb;11(2):155-160. doi: 10.1016/0195-6701(88)90058-8.

Grabe DW, Bailie GR, Eisele G, Venezia R. Limited Systemic Absorption of Intraperitoneal Ceftizoxime in a Patient with Serratia marcescens Peritonitis. Peritoneal Dialysis International. 1997;17(4):395-397. doi: 10.1177/089686089701700416.

Krishnan M, Thodis E, Ikonomopoulos D, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int. 2002 Sep-Oct;22(5):573-581.

Kang JH, Kim MJ, Kang YU, et al. Serratia marcescens Peritonitis in a Diabetic Patient Receiving Continuous Ambulatory Peritoneal Dialysis. Infect Chemother. 2013 Mar;45(1):105-107. doi: 10.3947/ic.2013.45.1.105.

Bhave P, Tregaskis P, Walker R, Wilson S. Intraperitoneal meropenem for peritoneal dialysis peritonitis with Serratia marcescens immediately on commencing dialysis. New Microbes New Infect. 2016 Jan 27;10:84-86. doi: 10.1016/j.nmni.2016.01.012.

Sarihan I, Demir E, Basaran S, Caliskan Y, Bozfakioglu S. Serratia marcescens, Morganella morganii, Klebsiella oxytoca related peritonitis attacks in a patient on automated peritoneal dialysis: A case report. Nefrologia. 2017 May-Jun;37(3):350-351. doi: 10.1016/j.nefro.2016.11.009.

Downloads

Published

2025-01-09

How to Cite

Nabil, H., Qods, Y., Rihab, D., Naima, O., & Loubna, B. (2025). Serratia marcescens peritoneal dialysis peritonitis: a clinical case and therapeutic approach. KIDNEYS, 13(4), 272–275. https://doi.org/10.22141/2307-1257.13.4.2024.483

Issue

Section

Clinical Observation

Similar Articles

You may also start an advanced similarity search for this article.